IP Library Granted Patent US 8,696,593
Granted Patent B2
US 8,696,593 · App. 11/528,218 · Granted Apr 15, 2014

Method and system for monitoring intracranial pressure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,696,593
App. No.
11/528,218
Granted
Apr 15, 2014
Kind
B2
Abstract

Embodiments of the present invention relate to a system and method for monitoring intracranial pressure. Embodiments of the present invention include emitting an electromagnetic wavelength into forehead tissue of a patient and detecting characteristics of the electromagnetic wavelength after the electromagnetic wavelength has been scattered by the tissue. The characteristics may include variations in the electromagnetic wavelength corresponding to a pulse. Further, embodiments of the present invention include analyzing the variations to identify venous pulsations, and determining whether intracranial pressure is elevated in the patient based on a correlation between the venous pulsations and levels of intracranial pressure.

Claims (44)

1. A method for monitoring intracranial pressure, comprising:

using a sensor:

emitting at least one electromagnetic wavelength into forehead tissue of a patient; and

detecting characteristics of the at least one electromagnetic wavelength after the at least one electromagnetic wavelength has been scattered by the tissue, wherein the characteristics include variations in the at least one electromagnetic wavelength corresponding to a pulse; and

using a monitor:

analyzing the variations to identify venous pulsations; and

determining whether intracranial pressure is elevated in the patient based on a correlation only between the venous pulsations and levels of intracranial pressure.

2. The method of claim 1 , comprising:

applying an increasing amount of pressure to the forehead tissue until the venous pulsations are abolished;

measuring the amount of pressure corresponding to abolishment of the venous pulsations; and

quantifying the intracranial pressure based on the measured amount of pressure.

3. The method of claim 1 , comprising:

elevating the forehead tissue relative to the heart of the patient until the venous pulsations are abolished;

measuring the elevation corresponding to abolishment of the venous pulsations; and

quantifying the intracranial pressure based on the measured elevation.

4. The method of claim 1 , comprising analyzing a shape of the variations to identify the venous pulsations based on a correlation between the shape and the venous pulsations.

5. The method of claim 1 , comprising analyzing a phase difference between variations in at least two electromagnetic wavelengths to identify the venous pulsations based on a correlation between the phase difference and the venous pulsations.

6. The method of claim 1 , comprising:

emitting a first electromagnetic wavelength into a first portion of the forehead tissue of the patient;

emitting a second electromagnetic wavelength into a different portion of the forehead tissue of the patient; and

comparing a ratio of the variations in the first electromagnetic wavelength and the variations in the second electromagnetic wavelength to identify the venous pulsations based on a correlation between the ratio and the venous pulsations.

7. The method of claim 1 , comprising identifying the venous pulsations by comparing a first oxygen saturation estimate obtained from the forehead tissue and a second oxygen saturation estimate from a different portion of the forehead tissue.

8. The method of claim 1 , comprising delivering a pharmaceutical to the patient to control elevated intracranial pressure when elevated intracranial pressure is determined to be present.

9. The method of claim 1 , comprising comparing saturation values from multiple sites or comparing phase differences between a pulse and an ECG to identify the venous pulsations.

10. A system for monitoring intracranial pressure, comprising:

a sensor comprising:

an emitter configured to emit at least one electromagnetic wavelength into tissue of a patient; and

a detector configured to detect the at least one electromagnetic wavelength after scattering by the tissue;

a monitor configured to be in electronic communication with the sensor, the monitor configured to analyze characteristics of the at least one detected electromagnetic wavelength to identify venous pulsations and to determine whether intracranial pressure is elevated in the patient based on a correlation only between the venous pulsations and levels of intracranial pressure; and

an adjustment measurement device configured to measure a level of adjustment corresponding to abolishment of identified venous pulsations.

11. The system of claim 10 , comprising:

an inflatable headband; and

a pump configured to inflate the headband to increase pressure between the sensor and the tissue.

12. The system of claim 10 , comprising an adjustable head elevator configured to elevate the tissue with respect to the heart of the patient.

13. The system of claim 10 , wherein the monitor comprises a pressure mapping system.

14. The system of claim 10 , wherein the monitor comprises a pulse oximeter.

15. A method, comprising:

directing a sensor to emit at least one electromagnetic wavelength into tissue of a patient;

determining whether venous pulsations are present in the tissue based on the received sensor signal;

if venous pulsations are present, adjusting an adjustment measurement device until venous pulsations cease; and

determining whether intracranial pressure is elevated in the patient based on a correlation only between the level at which venous pulsations cease and a level of intracranial pressure.

16. The method of claim 15 , wherein the adjustment measurement device is configured to measure an amount of pressure applied to the sensor.

17. The method of claim 15 , wherein the adjustment measurement device comprises a pressure sheet.

18. The method of claim 15 , wherein the adjustment measurement device is configured to measure an elevation relative to the heart of the patient.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029317/0260 →
CHANGE OF NAME Recorded Nov 5, 2012
From: NELLCOR PURITAN BENNETT INCORPORATED
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 029247/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2006
From: CAMPBELL, SHANNON E.; BAKER, CLARK R., JR.
To: NELLCOR PURITAN BENNETT INCORPORATED
Reel/Frame 018358/0893 →